Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Serv
Recalled October 11, 2023 · FDA recall D-0029-2024 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility: · FDA Class II
Units
4,550 30 mL syringes
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility:
Product
HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2011-1
Manufacturer(s)
Central Admixture Pharmacy Services Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →